Company News: Provecs Medical Signs Vaccine Collaboration with Bernhard Nocht Institute for Tropical Medicine

Hamburg-based immunotherapeutics company Provecs Medical this week announced the signing of a collaboration with the prestigious German Bernhard Nocht Institute for Tropical Medicine (BNI). The partners will design and evaluate novel vaccine candidates based on Provecs Medical’s technology platform. Indications are four undisclosed infectious diseases, three of them transmitted by insects.

Provecs Medical uses a proprietary adenoviral vector technology to achieve the targeted expression of multiple signaling molecules relevant for the immune system in the microenvironment of a disease site. Please click here for further information.